Theratechnologies (TH) Stock Price, News & Analysis

Company Overview

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Key Stats

• Today's Range: C$3.82 to C$4.10
• 50-Day Range: C$1.85 to C$4.04
• 52-Week Range: C$1.59 to C$4.33
• Volume: 103,578 shs
• Average Volume: 109,030 shs
• Market Capitalization: C$123.16 million
• P/E Ratio: N/A
• Dividend Yield: 3.76%
• Price Target: N/A
• Consensus Rating: Strong Buy

TH Stock Analysis - Frequently Asked Questions

How have TH shares performed this year?

Theratechnologies' stock was trading at C$2.62 at the beginning of 2025. Since then, TH stock has increased by 47.3% and is now trading at C$3.86.
View the best growth stocks for 2025 here.

How do I buy shares of Theratechnologies?

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include Theratechnologies (THTX), Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Vanguard Extended Duration Treasury ETF (EDV) and Nemaska Lithium (NMX).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Restaurants, Hotels, Motels
• Current Symbol: TSE:TH
• CIK: N/A
• Web: www.theratech.com
• Phone: +1-514-3367800
• Fax: N/A
• Employees: 103
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 129.25
• P/E Growth: -8.5
• Net Income: C$-1,955,821.23
• Net Margins: -3.75%
• Pretax Margin: N/A
• Return on Equity: 14.30%
• Return on Assets: 5.15%

Debt

• Debt-to-Equity Ratio: -293.92
• Current Ratio: 1.08
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: C$52.22 million
• Price / Sales: 2.36
• Cash Flow: C$1.03 per share
• Price / Cash Flow: 3.76
• Book Value: C($0.38) per share
• Price / Book: -10.11

Miscellaneous

• Outstanding Shares: 31,905,443
• Free Float: N/A
• Market Cap: C$123.16 million
• Optionable: Not Optionable
• Beta: 1.73